Polymyalgia rheumatica (PMR) immune-related adverse events (ICI-PMRs) represent a novel, distinct entity, despite many clinical, laboratory, and imaging similarities to classical PMR. Important questions remain in differentiating ICI-PMR from classical PMR, as well as other immune-related adverse events and PMR mimics. Despite this, ICI-PMR currently takes treatment cues from classical PMR, albeit with considerations relevant to cancer immunotherapy. Comparisons between ICI-PMR and classical PMR may provide further bidirectional insights, especially given that important questions remain unanswered about both diseases. The cause of classical PMR remains poorly understood, and ICI-PMR may represent a model of induced PMR, with important therapeutic implications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rdc.2024.02.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Decision-Making for Preventive Interventions in Asymptomatic Patients.
Stroke
July 2024
Department of Neurosurgery (A.R., D.B., J. Goldberg, I.Z.), Inselspital, Bern University Hospital, Switzerland.
Article Synopsis
- The decision to treat incidental findings in asymptomatic patients involves weighing the risks and benefits, often leading to complex choices.
- A common mistake in this decision-making process is relying on risk-based methods, like comparing Kaplan-Meier curves, which can be misleading about the true benefits of treatment.
- To improve decision-making and avoid unnecessary treatments, it's suggested to use an outcome-based approach, focusing on cumulative quality-adjusted life years lost rather than just comparing ongoing yearly risks.
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica.
Rheum Dis Clin North Am
May 2024
Department of Rheumatology, Austin Health, Heidelberg West VIC 3081, Australia; Department of Medicine, University of Melbourne, Parkville, Victoria 3052, Australia.
Polymyalgia rheumatica (PMR) immune-related adverse events (ICI-PMRs) represent a novel, distinct entity, despite many clinical, laboratory, and imaging similarities to classical PMR. Important questions remain in differentiating ICI-PMR from classical PMR, as well as other immune-related adverse events and PMR mimics. Despite this, ICI-PMR currently takes treatment cues from classical PMR, albeit with considerations relevant to cancer immunotherapy.
View Article and Find Full Text PDFCase Report and Literature Review of an Atypical Polymyalgia Rheumatica and Its Management.
Int Med Case Rep J
December 2023
Monash Health Rehabilitation and Aged Care Services, Melbourne, Australia.
Polymyalgia rheumatica (PMR) is a systemic inflammatory disease of the elderly population that increases in incidence as age advances. It is characterised by the sudden or sub-acute onset of symptoms affecting the shoulder and pelvic girdles, often accompanied by constitutional symptoms. Due to the lack of consensual diagnostic criteria and specific laboratory or radiological investigations for PMR, its diagnosis can be very challenging, particularly because it can be mimicked or masked by other geriatric syndromes.
View Article and Find Full Text PDFModeling of horizontal pleiotropy identifies possible causal gene expression in systemic lupus erythematosus.
Front Lupus
October 2023
Research Service, US Department of Veterans Affairs Medical Center, Cincinnati, OH, United States.
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune condition with complex causes involving genetic and environmental factors. While genome-wide association studies (GWASs) have identified genetic loci associated with SLE, the functional genomic elements responsible for disease development remain largely unknown. Mendelian Randomization (MR) is an instrumental variable approach to causal inference based on data from observational studies, where genetic variants are employed as instrumental variables (IVs).
View Article and Find Full Text PDFAberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.
Front Immunol
August 2023
Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Background: Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) are overlapping inflammatory diseases. Antigen-presenting cells (APCs), including monocytes and dendritic cells (DCs), are main contributors to the immunopathology of GCA and PMR. However, little is known about APC phenotypes in the peripheral blood at the time of GCA/PMR diagnosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!